SWS Hemodialysis Care Co., Ltd. (SHA:688410)

SWS Hemodialysis Care Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	200.03	145.89	70.89	194.5	59.24	19.47
Depreciation & Amortization	21.38	21.38	21.56	18.65	16.8	17.11
Other Amortization	1.76	1.76	0.86	1.18	1.83	2.31
Loss (Gain) From Sale of Assets	-0.03	-0.03	-0.35	-0.61	-0.05	-0.04
Asset Writedown & Restructuring Costs	13.04	13.04	8.64	0.16	0.38	0.41
Loss (Gain) From Sale of Investments	-18.67	-18.67	-22.21	-17.46	-1.87	-3.91
Provision & Write-off of Bad Debts	2.68	2.68	-1.73	3.4	3.03	1.67
Other Operating Activities	-41.68	9.74	3.9	6.73	1.05	1.08
Change in Accounts Receivable	-19.6	-19.6	-1.34	17.91	-12.03	-37.01
Change in Inventory	-41.4	-41.4	-14.86	-23.42	-74.95	13.78
Change in Accounts Payable	204.04	204.04	67.94	-149.12	252.31	17.65
Change in Other Net Operating Assets	-11.62	-11.62	11.94	16.8	1.57	2.24
Operating Cash Flow	310.74	308.01	143.15	64.55	245.85	32.76
Operating Cash Flow Growth	27.01%	115.17%	121.75%	-73.74%	650.41%	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-275.46	-156.14	-83.18	-112.52	-12.95	-28.08
Sale of Property, Plant & Equipment	0.01	0.93	0.02	0.15	0.18	0.75
Divestitures	-	-	1.5	2.6	-	-
Investment in Securities	327.6	-124.4	-109.1	-501.86	0.3	3.2
Other Investing Activities	19.94	18.02	21.29	13.08	5.32	2.63
Investing Cash Flow	72.09	-261.6	-169.47	-598.56	-7.15	-21.49

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Repaid	-	-2.46	-3.8	-16.2	-10.72	-78
Lease Payments	-2.46	-2.46	-3.8	-3.4	-2.72	-
Net Debt Issued (Repaid)	-2.46	-2.46	-3.8	-16.2	-10.72	-78
Issuance of Common Stock	-	-	14.12	-	1,089	-
Repurchase of Common Stock	-0.01	-0.01	-50.33	-	-	-
Common Dividends Paid	-153.39	-31.96	-43.13	-29.13	-0.74	-1.78
Dividends Paid	-153.39	-31.96	-43.13	-29.13	-0.74	-1.78
Other Financing Activities	-0.05	-14.11	-	-3.64	-20.15	0.65
Financing Cash Flow	-155.91	-48.55	-83.14	-48.96	1,058	-79.13

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.66	-1.28	0.01	-0.05	-0.03	0.02
Net Cash Flow	226.27	-3.42	-109.45	-583.01	1,296	-67.84

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	35.28	151.87	59.97	-47.97	232.9	4.69
Free Cash Flow Growth	-55.35%	153.24%	-	-	4870.12%	-
Free Cash Flow Margin	3.68%	18.82%	10.57%	-6.95%	60.97%	1.65%
Free Cash Flow Per Share	0.08	0.34	0.13	-0.11	0.52	0.01
Levered Free Cash Flow	40.24	158.72	57.93	-140.48	209	-24.45
Unlevered Free Cash Flow	40.33	158.89	58.11	-140.38	209.5	-23.44
Free Cash Flow After Leases	32.82	149.41	56.17	-51.37	230.18	4.69

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	39.71	21.66	20.07	-	12.65	14.52
Change in Working Capital	132.23	132.23	61.59	-142	165.43	-5.34

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error